Login / Signup

Supra-Blan 2 t score as a multisystem-based risk score to predict poor 3-month outcome in acute ischemic stroke patients with intravenous thrombolysis.

Huijuan JinQiwei PengMin LiShuai SunJinghua ZhouJichuan HuMing HuangXinglong ChenYanan LiYifan ZhouYan WanCandong HongShengcai ChenBo Hu
Published in: CNS neuroscience & therapeutics (2023)
t score, based on easily available multisystem laboratory and clinical variables, reliably predicted poor 3-month functional outcome in AIS patients treated with IVT therapy featuring good calibration and discrimination.
Keyphrases
  • high dose
  • acute ischemic stroke
  • stem cells
  • low cost
  • bone marrow
  • mesenchymal stem cells